Safety and Efficacy of Glucagon-like Peptide 1 Receptor Agonists in Patients With Cirrhosis

被引：5
|
作者：
Morris, Sean M. [1 ]
Armstrong, Matthew J. [1 ,2 ]
Newsome, Philip N. [1 ,2 ]
机构：
[1] Univ Birmingham, Inst Immunol & Immunotherapy, Ctr Liver & Gastrointestinal Res, Birmingham, W Midlands, England
[2] Univ Birmingham, Univ Hosp Birmingham NHS Fdn Trust, Biomed Res Ctr, Natl Inst Hlth Res, Birmingham, W Midlands, England
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2022年 / 20卷 / 06期
关键词：
D O I：
10.1016/j.cgh.2021.09.023
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1220 / 1222
页数：3
相关论文
共 50 条
  • [41] Glucagon-like peptide-1 agonists
    Padwal, Raj
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [42] Glucagon-like peptide receptor agonists and risk for depression
    Tagliapietra, Gabriella A.
    Cantrell, Matthew A.
    Lund, Brian C.
    PRIMARY CARE DIABETES, 2024, 18 (04) : 422 - 426
  • [43] Glucagon-Like Peptide-1 Agonists
    Stanton, Eloise W.
    Manasyan, Artur
    Banerjee, Rakhi
    Hong, Kurt
    Koesters, Emma
    Daar, David A.
    ANNALS OF PLASTIC SURGERY, 2025, 94 (01) : 121 - 127
  • [44] Perioperative Implications of Glucagon-like Peptide-1 Receptor Agonists
    Wolfe, Rachel C.
    JOURNAL OF PERIANESTHESIA NURSING, 2024, 39 (06) : 1108 - 1110
  • [45] Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists
    Chen, J.
    Cooper, M. E.
    Coughlan, M. T.
    DIABETES & METABOLISM, 2025, 51 (03)
  • [46] NEPHROPROTECTIVE POTENTIAL OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
    Shamhalova, Minara S.
    Sklyanik, Igor A.
    Shestakova, Marina V.
    DIABETES MELLITUS, 2020, 23 (01): : 56 - 64
  • [47] Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity
    Jepsen, Mathies M.
    Christensen, Mikkel B.
    EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (03) : 231 - 243
  • [48] Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management
    Taha, Mohamad B.
    Yahya, Tamer
    Satish, Priyanka
    Laird, Rachel
    Agatston, Arthur S.
    Cainzos-Achirica, Miguel
    Patel, Kershaw V.
    Nasir, Khurram
    CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (08) : 643 - 654
  • [49] Glucagon-like peptide-1 receptor agonists in neoplastic diseases
    Ji, Lisan
    He, Xianzhen
    Min, Xinwen
    Yang, Handong
    Wu, Wenwen
    Xu, Hao
    Chen, Jun
    Mei, Aihua
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [50] Renal protection with glucagon-like peptide-1 receptor agonists
    Vitale, Martina
    Haxhi, Jonida
    Cirrito, Tiziana
    Pugliese, Giuseppe
    CURRENT OPINION IN PHARMACOLOGY, 2020, 54 : 91 - 101
12345